Quick facts

Founding Year Team Members Headquarters

2013

Niel, Belgium
CEO Platforms Other locations

Steven Powell          

Learn More

              3 platforms         

    Learn More

Ghent,
Belgium

New York,
USA

Sheung Wan,
Hong Kong

Therapeutic
Areas
Capitalization Founding
Investors

          Oncology        

Infectious
Diseases

EUR 63 million
in equity investment    

Series A financing
of EUR 24 million
in 2016

Series B financing
of EUR 39 million
in 2019

Vrije Universiteit
Brussel

Progress Pharma

Current Shareholders